Faron Pharmaceuticals reports new data for cancer drug Clevegen
Faron Pharmaceuticals has reported new findings from the open-label Phase I/II MATINS clinical trial of its cancer immunotherapy Clevegen for…
Finland
Latest in
Finland
Faron says treatment for ARDS shows no improvement versus placebo
Faron Pharmaceuticals said clinical results from a study for the treatment of acute respiratory distress syndrome (ARDS) showed that the…
Bayer and Orion report positive data from trial of darolutamide
Bayer and Orion have reported positive results from a Phase III clinical trial (ARAMIS) of darolutamide in patients with non-metastatic…
Deals this week: DelSiTech, Marken, Erasca
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics.
Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma…
M&As this week: Tongyang, Glenmark Pharmaceuticals, Leerink Revelation Partners
Tongyang Networks Corporation has acquired a 29.72% stake in biotechnology company MediGene for KRW30.3bn ($28.02m).